Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
7.94
-0.08 (-1.06%)
Jun 11, 2025, 4:00 PM - Market closed
Elicio Therapeutics Market Cap
Elicio Therapeutics has a market cap or net worth of $126.82 million as of June 12, 2025. Its market cap has increased by 47.04% in one year.
Market Cap
126.82M
Enterprise Value
114.26M
1-Year Change
47.04%
Ranking
Category
Stock Price
$7.94
Market Cap Chart
Since June 2, 2023, Elicio Therapeutics's market cap has decreased from $312.21M to $126.82M, a decrease of -59.38%. That is a compound annual growth rate of -35.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 126.82M | 130.74% |
| Dec 31, 2024 | 54.96M | -31.39% |
| Dec 29, 2023 | 80.11M | -74.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 694.59B |
| Johnson & Johnson | 373.49B |
| AbbVie | 334.13B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.04B |
| Abbott Laboratories | 232.09B |
| Novartis AG | 231.17B |
| AstraZeneca | 226.45B |